Page last updated: 2024-09-04

schizandrer a and Injury, Ischemia-Reperfusion

schizandrer a has been researched along with Injury, Ischemia-Reperfusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, G; Guo, W; Liu, F; Lu, H; Zhan, Y; Zhang, M; Zheng, N1
Chen, C; Ding, F; Liang, XM; Shi, YW; Tang, M; Wang, CP; Wang, ZW; Zhang, XC1

Other Studies

2 other study(ies) available for schizandrer a and Injury, Ischemia-Reperfusion

ArticleYear
Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway.
    International immunopharmacology, 2017, Volume: 47

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cyclooctanes; Dioxoles; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Reperfusion Injury; Schisandraceae; Signal Transduction

2017
Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.
    Brain, behavior, and immunity, 2017, Volume: 66

    Topics: Animals; Apoptosis; Brain Ischemia; Cell Survival; Cerebral Cortex; Cyclooctanes; Dioxoles; Inflammation; Lignans; Necrosis; Neurons; Neuroprotective Agents; Oxidative Stress; Parietal Lobe; Primary Cell Culture; Rats, Sprague-Dawley; Receptor, Anaphylatoxin C5a; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4

2017